Comment
doi: 10.7326/J22-0059.
Epub 2022 Aug 2.
In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk
Affiliations
- PMID: 35914257
- DOI: 10.7326/J22-0059
Item in Clipboard
Comment
In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk
Ann Intern Med.
2022 Aug.
Abstract
Carbone F, Van den Houte K, Besard L, et al. Diet or medication in primary care patients with IBS: the DOMINO study-a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute. Gut. 2022. [Epub ahead of print]. 35483886.
Comment on
-
Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.Gut. 2022 Nov;71(11):2226-2232. doi: 10.1136/gutjnl-2021-325821. Epub 2022 Apr 28. Gut. 2022. PMID: 35483886 Free PMC article. Clinical Trial.
Similar articles
-
Use of an app to change dietary behaviour for IBS.Drug Ther Bull. 2023 Jan;61(1):5. doi: 10.1136/dtb.2022.000067. Epub 2022 Nov 29. Drug Ther Bull. 2023. PMID: 36446551
-
Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.Gut. 2022 Nov;71(11):2226-2232. doi: 10.1136/gutjnl-2021-325821. Epub 2022 Apr 28. Gut. 2022. PMID: 35483886 Free PMC article. Clinical Trial.
-
Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.World J Gastroenterol. 2014 Sep 14;20(34):12283-91. doi: 10.3748/wjg.v20.i34.12283. World J Gastroenterol. 2014. PMID: 25232263 Free PMC article. Clinical Trial.
-
The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):25-37. Eur Rev Med Pharmacol Sci. 2012. PMID: 22338545 Review.
-
Clinical application of dietary therapies in irritable bowel syndrome.J Gastrointestin Liver Dis. 2018 Sep;27(3):307-316. doi: 10.15403/jgld.2014.1121.273.avy. J Gastrointestin Liver Dis. 2018. PMID: 30240475 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
